These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 21811139

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection.
    Abner SR, Guenthner PC, Guarner J, Hancock KA, Cummins JE, Fink A, Gilmore GT, Staley C, Ward A, Ali O, Binderow S, Cohen S, Grohskopf LA, Paxton L, Hart CE, Dezzutti CS.
    J Infect Dis; 2005 Nov 01; 192(9):1545-56. PubMed ID: 16206069
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase.
    Zhang Z, Walker M, Xu W, Shim JH, Girardet JL, Hamatake RK, Hong Z.
    Antimicrob Agents Chemother; 2006 Aug 01; 50(8):2772-81. PubMed ID: 16870771
    [Abstract] [Full Text] [Related]

  • 11. In vitro evaluation of the anti-HIV activity and metabolic interactions of tenofovir and emtricitabine.
    Borroto-Esoda K, Vela JE, Myrick F, Ray AS, Miller MD.
    Antivir Ther; 2006 Aug 01; 11(3):377-84. PubMed ID: 16759055
    [Abstract] [Full Text] [Related]

  • 12. The future of HIV prevention: prospects for an effective anti-HIV microbicide.
    Nuttall J, Romano J, Douville K, Galbreath C, Nel A, Heyward W, Mitchnick M, Walker S, Rosenberg Z.
    Infect Dis Clin North Am; 2007 Mar 01; 21(1):219-39, x. PubMed ID: 17502237
    [Abstract] [Full Text] [Related]

  • 13. APHS can act synergically with clinically available HIV-1 reverse transcriptase and protease inhibitors and is active against several drug-resistant HIV-1 strains in vitro.
    Pereira CF, Paridaen JT, van de Bovenkamp M, Middel J, Verhoef J, Nottet HS.
    J Antimicrob Chemother; 2003 May 01; 51(5):1181-9. PubMed ID: 12668583
    [Abstract] [Full Text] [Related]

  • 14. Pre-incubation of cell-free HIV-1 group M isolates with non-nucleoside reverse transcriptase inhibitors blocks subsequent viral replication in co-cultures of dendritic cells and T cells.
    Njai HF, Lewi PJ, Janssen CG, Garcia S, Fransen K, Kestens L, Vanham G, Janssen PA.
    Antivir Ther; 2005 May 01; 10(2):255-62. PubMed ID: 15865220
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S, Antunes OA, Fortunak JM.
    Antiviral Res; 2008 Sep 01; 79(3):143-65. PubMed ID: 18571246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.